Takeda Pharmaceutical
389 hedge funds and large institutions have $3.64B invested in Takeda Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 308 funds opening new positions, 62 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
389
Holders Change
+297
Holders Change %
+322.83%
% of All Funds
8.43%
Holding in Top 10
16
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+1,500%
% of All Funds
0.35%
New
308
Increased
62
Reduced
14
Closed
9
Calls
$94.4M
Puts
$95.5M
Net Calls
-$1.07M
Net Calls Change
-$4.21M
Top Buyers
| 1 |
GCM
Glenview Capital Management
New York
|
+$532M |
| 2 |
PC
Paulson & Co
New York
|
+$270M |
| 3 |
BG
Baupost Group
Boston,
Massachusetts
|
+$217M |
| 4 |
AC
Adelphi Capital
London,
United Kingdom
|
+$189M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$154M |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$202M |
| 2 |
Citigroup
New York
|
-$128M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$91.6M |
| 4 |
Goldman Sachs
New York
|
-$47.7M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$23.8M |
